Current and historical daily PE Ratio for DRI Healthcare Trust (
) from 2021 to Apr 27 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. DRI Healthcare Trust stock (TSX:DHT.U) PE ratio as of Apr 27 2024 is 5.41.
More Details
DRI Healthcare Trust (TSX:DHT.U) PE Ratio (TTM) Chart
DRI Healthcare Trust (TSX:DHT.U) PE Ratio (TTM) Historical Data
View and export this data going back to 2021. Start your Free Trial
Total 605
- 1
- 2
- 3
- 4
- 5
- 6
- 7
| DRI Healthcare Trust PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-04-27 | 5.6 | 2024-02-26 | 4.8 |
| 2024-04-26 | 5.6 | 2024-02-23 | 4.8 |
| 2024-04-25 | 5.6 | 2024-02-22 | 4.8 |
| 2024-04-24 | 5.6 | 2024-02-21 | 4.8 |
| 2024-04-23 | 5.6 | 2024-02-20 | 4.8 |
| 2024-04-22 | 5.4 | 2024-02-19 | 4.8 |
| 2024-04-19 | 5.4 | 2024-02-16 | 4.8 |
| 2024-04-18 | 5.4 | 2024-02-15 | 4.6 |
| 2024-04-17 | 5.6 | 2024-02-14 | 4.6 |
| 2024-04-16 | 5.6 | 2024-02-13 | 4.6 |
| 2024-04-15 | 5.6 | 2024-02-12 | 4.9 |
| 2024-04-12 | 5.6 | 2024-02-09 | 4.9 |
| 2024-04-11 | 5.6 | 2024-02-08 | 4.9 |
| 2024-04-10 | 5.7 | 2024-02-07 | 4.8 |
| 2024-04-09 | 5.6 | 2024-02-06 | 4.8 |
| 2024-04-08 | 5.7 | 2024-02-05 | 4.7 |
| 2024-04-05 | 5.4 | 2024-02-02 | 4.6 |
| 2024-04-04 | 5.4 | 2024-02-01 | 4.6 |
| 2024-04-03 | 5.4 | 2024-01-31 | 4.6 |
| 2024-04-02 | 5.3 | 2024-01-30 | 4.5 |
| 2024-04-01 | 5.3 | 2024-01-29 | 4.5 |
| 2024-03-29 | 5.2 | 2024-01-26 | 4.5 |
| 2024-03-28 | 5.2 | 2024-01-25 | 4.4 |
| 2024-03-27 | 5.2 | 2024-01-24 | 4.5 |
| 2024-03-26 | 5.2 | 2024-01-23 | 4.5 |
| 2024-03-25 | 5.2 | 2024-01-22 | 4.4 |
| 2024-03-22 | 5.2 | 2024-01-19 | 4.2 |
| 2024-03-21 | 5.1 | 2024-01-18 | 4.2 |
| 2024-03-20 | 5.1 | 2024-01-17 | 4.2 |
| 2024-03-19 | 5.1 | 2024-01-16 | 4.2 |
| 2024-03-18 | 5.3 | 2024-01-15 | 4.3 |
| 2024-03-15 | 5.3 | 2024-01-12 | 4.3 |
| 2024-03-14 | 5.3 | 2024-01-11 | 4.3 |
| 2024-03-13 | 5.3 | 2024-01-10 | 4.3 |
| 2024-03-12 | 5.3 | 2024-01-09 | 4.3 |
| 2024-03-11 | 5.4 | 2024-01-08 | 4.3 |
| 2024-03-08 | 5.4 | 2024-01-05 | 4.3 |
| 2024-03-07 | 5.4 | 2024-01-04 | 4.2 |
| 2024-03-06 | 5.4 | 2024-01-03 | 4.3 |
| 2024-03-05 | 5.4 | 2024-01-02 | 4.3 |
| 2024-03-04 | 5.3 | 2024-01-01 | 4.3 |
| 2024-03-01 | 5.2 | 2023-12-29 | 4.3 |
| 2024-02-29 | 4.8 | 2023-12-28 | 4.3 |
| 2024-02-28 | 4.8 | 2023-12-27 | 5.4 |
| 2024-02-27 | 4.8 | 2023-12-22 | 5.4 |
DRI Healthcare Trust (TSX:DHT.U) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
DRI Healthcare Trust
NAICS : 325412
SIC : 3741
ISIN : CA23344H1091
Share Class Description:
TSX:DHT.U: UnitsCompare
Compare
Traded in other countries / regions
DHT.UN.CanadaDHTRF.USA3IJ0.Germany IPO Date
2021-02-19Description
DRI Healthcare Trust is engaged in pharmaceutical royalty monetization by providing capital to inventors, academic institutions, and biopharma companies. Trust was formed to provide Unitholders with differential exposure to the pharmaceutical and biotechnology industries through ownership and acquisitions of pharmaceutical royalties. In return for providing capital to biopharmaceutical innovators, the company is building a diversified portfolio of interests in medicines that have a demonstrable positive impact on the world. The Trust has concluded that it operates as one segment, primarily focused on acquiring royalty assets. Geographically the trust generates major revenue from the United States. The trust also generates Income from markets such as Japan, and the European Union.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers